Hengrui Pharmaceuticals: As of the end of March, a total of 11.9474 million shares have been repurchased, costing 766 million yuan.

Hengrui Pharmaceuticals announced that the company will implement a share buyback plan starting on August 20, 2025, for the employee stock ownership plan, with an expected buyback amount of 1-2 billion yuan. In March 2026, the company bought back 1.253 million shares, and has already paid 68.1388 million yuan. As of March 31, a total of 11.9474 million shares have been repurchased, accounting for 0.18% of the total share capital, with a total payment of 766 million yuan, at a purchase price of 53.52 - 70.00 yuan per share.